MTANZ board member Aisling Weir explores the history and complexities of medical device regulation in New Zealand. She discusses the challenges and opportunities within the evolving landscape of medical technology and how new legislation - the Medical Products Bill - aims to address these issues. Also, the difficulty of regulating AI in relation to medical devices and what New Zealand could learn from how international regulatory agencies are approaching this.
All content for eHealthTALK NZ is the property of Rebecca McBeth and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
MTANZ board member Aisling Weir explores the history and complexities of medical device regulation in New Zealand. She discusses the challenges and opportunities within the evolving landscape of medical technology and how new legislation - the Medical Products Bill - aims to address these issues. Also, the difficulty of regulating AI in relation to medical devices and what New Zealand could learn from how international regulatory agencies are approaching this.
25 Years of HiNZ - where we've been and where we're going
eHealthTALK NZ
18 minutes
5 months ago
25 Years of HiNZ - where we've been and where we're going
HiNZ CEO Scott Arrol reflects on 25 years of HiNZ in Aotearoa and his vision for the future. From the organisation’s roots in nursing informatics to its role today as the trusted community for digital health, Scott discusses his own background in health and the evolving challenges and opportunities facing the sector. Celebrate the 25th anniversary of HiNZ at Digital Health Week 2025 in Ōtautahi Christchurch - register to attend online
eHealthTALK NZ
MTANZ board member Aisling Weir explores the history and complexities of medical device regulation in New Zealand. She discusses the challenges and opportunities within the evolving landscape of medical technology and how new legislation - the Medical Products Bill - aims to address these issues. Also, the difficulty of regulating AI in relation to medical devices and what New Zealand could learn from how international regulatory agencies are approaching this.
